BSEOthersMgmt Change26 Aug 2026
Lasa Supergenerics Ltd
Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today i.e . August 26, 2026 which was commenced at 11.00 a.m. and concluded at 1.00 p.m ....
Lasa Supergenerics Ltd has appointed Mr. Janardan Savala as an Additional Director in the capacity of Executive Director, subject to approval from members at the ensuing General Meeting/Postal Ballot.
BSECompany UpdateMgmt Change25 Aug 2026
Lasa Supergenerics Ltd
Resignation of Mr. Ganesh Potdar executive director as on 25-08-2026
Lasa Supergenerics Ltd has announced the resignation of Mr. Ganesh Potdar as Whole-time Director of the company, effective August 25, 2026, citing personal commitments.
BSECompany UpdateResults14 Aug 2026
Lasa Supergenerics Ltd
Integrated filing for Quarter ended June 30, 2026
Lasa Supergenerics Ltd has submitted its integrated filing for the quarter ended June 30, 2026, along with unaudited financial results and a limited review report from its statutory auditor. The company's board of directors has approved the unaudited financial results and the limited review report. The auditor's report draws attention to an exceptional item, an uninsured loss due to a fire incident at the company's factory in May 2025.
BSEBoard MeetingResults14 Aug 2026
Lasa Supergenerics Ltd
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held ....
Lasa Supergenerics Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors considering and approving the results. The company has also drawn attention to exceptional items, including a fire incident at its factory, resulting in a loss of Rs.2057.47 Lacs, and impairment of tangible assets.
BSEBoard MeetingResults4 Aug 2026
Lasa Supergenerics Ltd
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Lasa Supergenerics Ltd has scheduled a board meeting on August 14, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026. The trading window remains closed till 48 hours after the declaration of results.